(Q46057383)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18436274%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

Variable contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18436274%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18436274%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Luiz Mario Janini

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18436274%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

9

Francine E McCutchan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18436274%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

4

Eric Sanders-Buell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18436274%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

3

Sodsai Tovanabutra

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18436274%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

6

Merlin L Robb

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18436274%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

7

Nelson L Michael

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18436274%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1

Gustavo H Kijak

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18436274%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

8

Debora L Birx

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18436274%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

language of work or name

English

0 references

publication date

24 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18436274%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

19 December 2017

http://europepmc.org/abstract/MED/18436274

volume

376

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18436274%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18436274%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

101-111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18436274%20AND%20SRC:MED&resulttype=core&format=json

APOBEC3G genetic variants and their influence on the progression to AIDS.

6 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

The unusual nucleotide content of the HIV RNA genome results in a biased amino acid composition of HIV proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Cytidine deamination of retroviral DNA by diverse APOBEC proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Characterization of subtype A HIV-1 from Africa by full genome sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

APOBEC3G DNA deaminase acts processively 3' --> 5' on single-stranded DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

The nuclear DNA deaminase AID functions distributively whereas cytoplasmic APOBEC3G has a processive mode of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Identification of a simian immunodeficiency virus reverse transcriptase variant with enhanced replicational fidelity in the late stage of viral infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Exhaustive genotyping of the CEM15 (APOBEC3G) gene and absence of association with AIDS progression in a French cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

A new type of G-->A hypermutation affecting human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Retrovirus restriction factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

A cluster of HIV type 1 subtype C sequences from Ethiopia, observed in full genome analysis, is not sustained in subgenomic regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Retroviral restriction by APOBEC proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

APOBEC3G/CEM15 (hA3G) mRNA levels associate inversely with human immunodeficiency virus viremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

APOBEC3G levels predict rates of progression to AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

HyperPack: a software package for the study of levels, contexts, and patterns of APOBEC-mediated hypermutation in HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Hypermutation of HIV-1 DNA in the Absence of the Vif Protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Hypermutagenesis of RNA using human immunodeficiency virus type 1 reverse transcriptase and biased dNTP concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Lentiviral genomes with G-to-A hypermutation may result from Taq polymerase errors during polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Population level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

STAT1-independent cell type-specific regulation of antiviral APOBEC3G by IFN-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Twin gradients in APOBEC3 edited HIV-1 DNA reflect the dynamics of lentiviral replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Characterization of complete HIV type 1 genomes from non-B subtype infections in U.S. military personnel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

APOBEC3G genetic variants and their association with risk of HIV infection in highly exposed Caucasians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

G-->A hypermutation of the human immunodeficiency virus type 1 genome: evidence for dCTP pool imbalance during reverse transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Biochemical differentiation of APOBEC3F and APOBEC3G proteins associated with HIV-1 life cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Stoichiometry of the antiviral protein APOBEC3G in HIV-1 virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Cell-specific regulation of APOBEC3F by interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017

Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.017